The Lancet The Lancet, Elsevier, 2019, 394 (10204), pp.1169-1180. ⟨10.1016/S0140-6736(19)31887-2⟩ The Lancet (London), 394, 1169-1180 Bhatt, D L, Steg, P G, Mehta, S R, Leiter, L A, Simon, T, Fox, K, Held, C, Andersson, M, Himmelmann, A, Ridderstråle, W, Chen, J, Song, Y, Diaz, R, Goto, S, James, S K, Ray, K K, Parkhomenko, A N, Kosiborod, M N, McGuire, D K, Harrington, R A & THEMIS Steering Committee and Investigators 2019, ' Ticagrelor in patients with diabetes and stable coronary artery disease with a history of previous percutaneous coronary intervention (THEMIS-PCI) : a phase 3, placebo-controlled, randomised trial ', Lancet, vol. 394, no. 10204, pp. 1169-1180 . https://doi.org/10.1016/S0140-6736(19)31887-2 The Lancet (London), 394, 10204, pp. 1169-1180
INSPIRE-HEP Web of Science Repositório Institucional da UNESP Universidade Estadual Paulista (UNESP) instacron:UNESP Journal of high energy physics, 2018 (7), Article: 153 Journal of High Energy Physics, Vol 2018, Iss 7, Pp 1-45 (2018) JHEP JHEP, 2018, 07, pp.153. ⟨10.1007/JHEP07(2018)153⟩ JOURNAL OF HIGH ENERGY PHYSICS Journal of High Energy Physics Journal of High Energy Physics, 2018, 07, pp.153. ⟨10.1007/JHEP07(2018)153⟩ Journal of high energy physics 1807(07), 153 (2018). doi:10.1007/JHEP07(2018)153 Journal of high energy physics Journal of high energy physics : JHEP 2018(7), 153 (2018). doi:10.1007/JHEP07(2018)153